Oxidative stress in systemic lupus erythematosus and antiphospholipid syndrome: A gateway to atherosclerosis
Authors:
- José Delgado AlvesJAJosé Delgado Alves
- Bruno GrimaBGBruno Grima
- 1 October 2003
- journal article
- review article
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 5 (5) , 383-390
Abstract
Vascular disease and atherosclerosis are significant clinical features of systemic lupus erythematosus and antiphospholipid syndrome. Oxidation is one of the major factors responsible for atheroma development in this context. Anticardiolipin antibodies seem to play an important role by inducing nitric oxide and superoxide production, resulting in enhanced levels of plasma peroxynitrite, which is a powerful pro-oxidant substance. Furthermore, direct interference of these antibodies with paraoxonase activity, a high-density lipoprotein-related anti-oxidant enzyme, would contribute to the oxidative stress found in these conditions. The accelerated process of atherogenesis found in these diseases can represent a useful model for the study of atherosclerosis in the general population.Keywords
This publication has 49 references indexed in Scilit:
- Antibodies to high‐density lipoprotein and β2‐glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndromeArthritis & Rheumatism, 2002
- Human Serum Paraoxonase/Arylesterase’s Retained HydrophobicN-Terminal Leader Sequence Associates With HDLs by Binding PhospholipidsArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Cardiovascular effect of L-arginineCurrent Opinion in Nephrology and Hypertension, 1998
- Nitric oxide in excitable tissues: physiological roles and disease.Journal of Clinical Investigation, 1997
- Selection of a gene for apolipoprotein a1 using autoantibodies from a patient with systemic lupus erythematosusArthritis & Rheumatism, 1995
- Monoclonal anticardiolipin autoantibodies established from the (new zealand white x bxsb)f1 mouse model of antiphospholipid syndrome cross‐react with oxidized low‐density lipoproteinArthritis & Rheumatism, 1995
- Nitric oxide donor compounds inhibit the toxicity of oxidized low‐density lipoprotein to endothelial cellsFEBS Letters, 1995
- Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- STIMULATION OF VON WILLEBRAND FACTOR ANTIGEN RELEASE BY IMMUNOGLOBULIN FROM THROMBOSIS PRONE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND THE ANTIPHOSPHOLIPID SYNDROMERheumatology, 1993
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987